Klebsiella pneumoniae, an important opportunistic pathogen, exists as a biofilm in persistent
infections and in-dwelling medical devices. With the objective of identifying natural …

The ability of Klebsiella pneumoniae to form biofilm renders the pathogen recalcitrant to
various antibiotics. The difficulty in managing K. pneumoniae related chronic infections is …

The emergence of multidrug resistance (MDR) and extensive drug resistance (XDR) in
Klebsiella pneumoniae strains has posed great threats to conventional antibiotics. Previous …

Aim This study aimed to test biofilm inhibition activities of each of essential oils (EOs), main
compounds of EOs and enzymes against pathogenic Klebsiella pneumoniae. Methods and …

Klebsiella pneumoniae is responsible for a significant proportion of human urinary tract
infections, and its biofilm is a major virulence. One potential approach to controlling biofilm …

Background. Thymol and piperine are two naturally occurring bioactive compounds with
several pharmacological activities. In this study, their antibiofilm potential either alone or in …

Background: Klebsiella pneumoniae is among the most frequently recovered etiologic
agents from nosocomial infections. This opportunistic pathogen can generate a thick layer of …

Aim. Klebsiella pneumoniae (K. pneumoniae) is an encapsulated Gram‐negative bacterium
that can lead to 14–20% of nosocomial infections. The ability of biofilm formation in this …

Infections caused by biofilm-embedded pathogens decrease the efficacy of traditional
treatments and increase antibiotic tolerance. Most of the human bacterial infections are …

Background Klebsiella pneumoniae (K. pneumoniae) is a common cause of health-care
associated infections (HAIs) and has high levels of antibiotic resistance. These bacteria are …